+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

GLP-1 Agonists Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

GLP-1 Agonists Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Type 2 Diabetes Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Type 2 Diabetes Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Severe Hypertriglyceridemia Pipeline Analysis Report 2025 - Product Thumbnail Image

Severe Hypertriglyceridemia Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Hypoglycemia Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Hypoglycemia Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034 - Product Thumbnail Image

United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 250 Pages
  • United States
From
Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034 - Product Thumbnail Image

Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 300 Pages
  • Europe
From
Type 2 Diabetes Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034) - Product Thumbnail Image

Type 2 Diabetes Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034 - Product Thumbnail Image

Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034

  • Report
  • May 2025
  • 300 Pages
  • Global
From
Type 2 Diabetes Pipeline Analysis Report - Product Thumbnail Image

Type 2 Diabetes Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
United Kingdom Diabetes Market Size, Share, Trends and Forecast by Segment and Distribution Channel, 2026-2034 - Product Thumbnail Image

United Kingdom Diabetes Market Size, Share, Trends and Forecast by Segment and Distribution Channel, 2026-2034

  • Report
  • June 2026
  • 138 Pages
  • United Kingdom
From
France Diabetes Market Size, Share, Trends and Forecast by Product Type, 2026-2034 - Product Thumbnail Image

France Diabetes Market Size, Share, Trends and Forecast by Product Type, 2026-2034

  • Report
  • March 2026
  • 136 Pages
  • France
From
Hyperinsulinemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Hyperinsulinemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 128 Pages
  • Global
From
Post-Bariatric Hypoglycemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Post-Bariatric Hypoglycemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 140 Pages
  • Global
From
Type 2 Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Type 2 Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 140 Pages
  • Global
From
Lipodystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Lipodystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 139 Pages
  • Global
From
Prediabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Prediabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 130 Pages
  • Global
From
Diabetic Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Diabetic Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
China Diabetes Care Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

China Diabetes Care Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • August 2026
  • 70 Pages
  • China
From
Egypt Diabetes Care Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Egypt Diabetes Care Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • August 2026
  • 70 Pages
  • Egypt
From
Mexico Diabetes Care Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Mexico Diabetes Care Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • August 2026
  • 70 Pages
  • Mexico
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more